$199 Million is the total value of Virtus ETF Advisers LLC's 156 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 11.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ETP | Buy | ENERGY TRANSFER PRTNRS L Punit ltd partn | $16,056,000 | +61.4% | 433,945 | +66.1% | 7.76% | +5.2% |
WPZ | Buy | WILLIAMS PARTNERS L P NEW | $14,380,000 | +75.6% | 386,665 | +63.6% | 6.95% | +14.4% |
BPL | Buy | BUCKEYE PARTNERS L Punit ltd partn | $11,149,000 | +85.4% | 155,711 | +82.1% | 5.39% | +20.8% |
SXL | Buy | SUNOCO LOGISTICS PRTNRS L P | $9,790,000 | +46.1% | 344,589 | +47.9% | 4.73% | -4.8% |
ET | Buy | ENERGY TRANSFER EQUITY L P | $8,956,000 | +100.0% | 533,428 | +71.2% | 4.33% | +30.3% |
EEP | Buy | ENBRIDGE ENERGY PARTNERS L P | $8,847,000 | +64.9% | 347,910 | +50.5% | 4.28% | +7.4% |
MPLX | Buy | MPLX LP | $8,671,000 | +51.5% | 256,093 | +50.5% | 4.19% | -1.3% |
EPD | Buy | ENTERPRISE PRODS PARTNERS L | $7,471,000 | +67.5% | 270,408 | +77.4% | 3.61% | +9.1% |
PAA | Buy | PLAINS ALL AMERN PIPELINE Lunit ltd partn | $6,557,000 | +69.1% | 208,765 | +48.0% | 3.17% | +10.1% |
OKS | Buy | ONEOK PARTNERS LPunit ltd partn | $6,204,000 | +50.1% | 155,289 | +50.5% | 3.00% | -2.2% |
MMP | Buy | MAGELLAN MIDSTREAM PRTNRS LP | $5,947,000 | +30.4% | 84,065 | +40.0% | 2.88% | -15.1% |
TLLP | Buy | TESORO LOGISTICS LP | $5,595,000 | +47.2% | 115,509 | +50.5% | 2.70% | -4.1% |
ENLK | Buy | ENLINK MIDSTREAM PARTNERS LP | $5,402,000 | +60.2% | 305,029 | +50.5% | 2.61% | +4.4% |
EQM | Buy | EQT MIDSTREAM PARTNERS LPunit ltd partn | $4,730,000 | +42.8% | 62,081 | +50.5% | 2.29% | -7.0% |
WES | Buy | WESTERN GAS PARTNERS LP | $4,188,000 | +64.4% | 76,076 | +50.5% | 2.02% | +7.1% |
GEL | Buy | GENESIS ENERGY L Punit ltd partn | $3,646,000 | +52.0% | 96,031 | +53.7% | 1.76% | -1.0% |
CEQP | Buy | CRESTWOOD EQUITY PARTNERS LPunit ltd partner | $3,206,000 | +36.8% | 150,870 | +29.8% | 1.55% | -10.9% |
IGM | New | ISHARES TRn amer tech etf | $2,706,000 | – | 21,894 | +100.0% | 1.31% | – |
PSXP | Buy | PHILLIPS 66 PARTNERS LP | $2,608,000 | +30.9% | 53,654 | +50.5% | 1.26% | -14.7% |
NGL | Buy | NGL ENERGY PARTNERS LP | $2,195,000 | +46.7% | 116,498 | +50.5% | 1.06% | -4.4% |
DCP | Buy | DCP MIDSTREAM PARTNERS LP | $2,180,000 | +62.6% | 61,691 | +58.6% | 1.05% | +5.9% |
IYE | New | ISHARES TRu.s. energy etf | $2,037,000 | – | 52,234 | +100.0% | 0.98% | – |
WMB | Sell | WILLIAMS COS INC DEL | $1,866,000 | -62.0% | 60,720 | -73.3% | 0.90% | -75.3% |
TLT | New | ISHARES TR20 yr tr bd etf | $1,692,000 | – | 12,306 | +100.0% | 0.82% | – |
TSRO | Buy | TESARO INC | $1,511,000 | +36.4% | 15,077 | +14.4% | 0.73% | -11.1% |
TCP | Buy | TC PIPELINES LP | $1,332,000 | +49.8% | 23,352 | +50.5% | 0.64% | -2.4% |
WGP | Buy | WESTERN GAS EQUITY PARTNERS | $1,317,000 | +67.1% | 30,996 | +50.5% | 0.64% | +8.9% |
UBT | New | PROSHARES TRultra 20yr tre | $1,239,000 | – | 12,760 | +100.0% | 0.60% | – |
SHLX | Buy | SHELL MIDSTREAM PARTNERS L Punit ltd int | $1,227,000 | +42.8% | 38,250 | +50.4% | 0.59% | -7.1% |
VNQ | New | VANGUARD INDEX FDSreit etf | $1,214,000 | – | 13,991 | +100.0% | 0.59% | – |
EXEL | Buy | EXELIXIS INC | $1,086,000 | +87.2% | 84,932 | +14.4% | 0.52% | +22.1% |
ARIA | Buy | ARIAD PHARMACEUTICALS INC | $1,036,000 | +111.9% | 75,645 | +14.4% | 0.50% | +38.0% |
RPTP | Buy | RAPTOR PHARMACEUTICAL CORP | $1,023,000 | +91.2% | 114,022 | +14.4% | 0.50% | +24.7% |
IONS | Buy | IONIS PHARMACEUTICALS INC | $1,021,000 | +80.1% | 27,856 | +14.4% | 0.49% | +17.3% |
TBPH | Buy | THERAVANCE BIOPHARMA INC | $1,009,000 | +82.8% | 27,829 | +14.4% | 0.49% | +19.0% |
VNDA | Buy | VANDA PHARMACEUTICALS INC | $957,000 | +70.0% | 57,536 | +14.4% | 0.46% | +10.8% |
SGEN | Buy | SEATTLE GENETICS INC | $865,000 | +53.1% | 16,008 | +14.4% | 0.42% | -0.2% |
PGNX | Buy | PROGENICS PHARMACEUTICALS IN | $857,000 | +71.7% | 135,340 | +14.4% | 0.41% | +11.9% |
HALO | Buy | HALOZYME THERAPEUTICS INC | $847,000 | +60.1% | 70,108 | +14.4% | 0.41% | +4.3% |
RTRX | Buy | RETROPHIN INC | $841,000 | +43.8% | 37,593 | +14.4% | 0.41% | -6.2% |
ENLC | Buy | ENLINK MIDSTREAM LLC | $836,000 | +58.3% | 49,935 | +50.5% | 0.40% | +3.1% |
SE | Buy | SPECTRA ENERGY CORP | $818,000 | +37.0% | 19,142 | +17.4% | 0.40% | -10.8% |
BIIB | Buy | BIOGEN INC | $806,000 | +48.2% | 2,575 | +14.4% | 0.39% | -3.5% |
SRPT | SAREPTA THERAPEUTICS INC | $795,000 | +221.9% | 12,949 | 0.0% | 0.38% | +109.8% | |
TRGP | Sell | TARGA RES CORP | $769,000 | -28.6% | 15,655 | -38.8% | 0.37% | -53.4% |
IRWD | Buy | IRONWOOD PHARMACEUTICALS INC | $768,000 | +38.9% | 48,372 | +14.4% | 0.37% | -9.5% |
INCY | Buy | INCYTE CORP | $736,000 | +35.0% | 7,804 | +14.4% | 0.36% | -11.9% |
ICPT | Buy | INTERCEPT PHARMACEUTICALS IN | $721,000 | +32.1% | 4,378 | +14.4% | 0.35% | -13.8% |
BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $711,000 | +36.2% | 7,681 | +14.4% | 0.34% | -11.1% |
NKTR | Buy | NEKTAR THERAPEUTICS | $711,000 | +38.3% | 41,365 | +14.4% | 0.34% | -9.7% |
ENTA | Buy | ENANTA PHARMACEUTICALS INC | $709,000 | +37.9% | 26,649 | +14.4% | 0.34% | -10.0% |
UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $685,000 | +27.6% | 5,804 | +14.4% | 0.33% | -17.0% |
REGN | Buy | REGENERON PHARMACEUTICALS | $683,000 | +31.6% | 1,698 | +14.3% | 0.33% | -14.3% |
AMGN | Buy | AMGEN INC | $679,000 | +25.5% | 4,071 | +14.5% | 0.33% | -18.4% |
PDLI | Buy | PDL BIOPHARMA INC | $666,000 | +22.0% | 198,901 | +14.4% | 0.32% | -20.5% |
CELG | Buy | CELGENE CORP | $644,000 | +21.3% | 6,162 | +14.4% | 0.31% | -21.1% |
CLVS | CLOVIS ONCOLOGY INC | $644,000 | +162.9% | 17,865 | 0.0% | 0.31% | +70.9% | |
MNTA | Buy | MOMENTA PHARMACEUTICALS INC | $644,000 | +23.8% | 55,093 | +14.4% | 0.31% | -19.4% |
MDCO | Buy | MEDICINES CO | $644,000 | +28.3% | 17,070 | +14.4% | 0.31% | -16.6% |
MACK | Buy | MERRIMACK PHARMACEUTICALS IN | $636,000 | +34.7% | 100,090 | +14.4% | 0.31% | -12.0% |
OMER | Buy | OMEROS CORP | $624,000 | +21.4% | 55,936 | +14.4% | 0.30% | -20.7% |
VRTX | Buy | VERTEX PHARMACEUTICALS INC | $594,000 | +16.0% | 6,814 | +14.4% | 0.29% | -24.5% |
GILD | Buy | GILEAD SCIENCES INC | $589,000 | +8.5% | 7,450 | +14.4% | 0.28% | -29.3% |
ALXN | Buy | ALEXION PHARMACEUTICALS INC | $581,000 | +20.0% | 4,745 | +14.4% | 0.28% | -21.7% |
KERX | Buy | KERYX BIOPHARMACEUTICALS INC | $562,000 | -8.3% | 105,877 | +14.4% | 0.27% | -40.2% |
ARNA | Buy | ARENA PHARMACEUTICALS INC | $556,000 | +17.1% | 317,632 | +14.4% | 0.27% | -23.8% |
LGND | Buy | LIGAND PHARMACEUTICALS INC | $549,000 | -2.1% | 5,382 | +14.4% | 0.26% | -36.3% |
PBYI | PUMA BIOTECHNOLOGY INC | $514,000 | +125.4% | 7,666 | 0.0% | 0.25% | +47.3% | |
CQP | Buy | CHENIERE ENERGY PARTNERS LP | $515,000 | +47.1% | 17,587 | +50.5% | 0.25% | -4.2% |
VTAE | VITAE PHARMACEUTICALS INC | $512,000 | +93.9% | 24,463 | 0.0% | 0.25% | +26.5% | |
ARRY | ARRAY BIOPHARMA INC | $507,000 | +89.9% | 75,100 | 0.0% | 0.24% | +23.7% | |
ACOR | Buy | ACORDA THERAPEUTICS INC | $505,000 | -6.3% | 24,177 | +14.4% | 0.24% | -39.0% |
ACAD | Buy | ACADIA PHARMACEUTICALS INC | $505,000 | +12.2% | 15,878 | +14.4% | 0.24% | -26.9% |
PTCT | PTC THERAPEUTICS INC | $488,000 | +99.2% | 34,849 | 0.0% | 0.24% | +29.7% | |
GDX | New | VANECK VECTORS ETF TRgold miners etf | $487,000 | – | 18,431 | +100.0% | 0.24% | – |
AGEN | AGENUS INC | $454,000 | +77.3% | 63,191 | 0.0% | 0.22% | +15.8% | |
XNCR | XENCOR INC | $432,000 | +29.0% | 17,649 | 0.0% | 0.21% | -16.1% | |
BLUE | BLUEBIRD BIO INC | $418,000 | +56.6% | 6,165 | 0.0% | 0.20% | +2.0% | |
SAGE | SAGE THERAPEUTICS INC | $404,000 | +53.0% | 8,774 | 0.0% | 0.20% | -0.5% | |
BLCM | BELLICUM PHARMACEUTICALS INC | $404,000 | +53.6% | 20,302 | 0.0% | 0.20% | 0.0% | |
BPMC | BLUEPRINT MEDICINES CORP | $387,000 | +46.6% | 13,046 | 0.0% | 0.19% | -4.6% | |
RDUS | RADIUS HEALTH INC | $378,000 | +47.1% | 6,986 | 0.0% | 0.18% | -4.2% | |
SGYPQ | SYNERGY PHARMACEUTICALS DEL | $376,000 | +45.2% | 68,254 | 0.0% | 0.18% | -5.2% | |
BCRX | BIOCRYST PHARMACEUTICALS | $374,000 | +55.2% | 84,907 | 0.0% | 0.18% | +1.1% | |
NLNK | NEWLINK GENETICS CORP | $367,000 | +33.5% | 24,463 | 0.0% | 0.18% | -13.2% | |
NERV | MINERVA NEUROSCIENCES INC | $362,000 | +38.2% | 25,630 | 0.0% | 0.18% | -9.8% | |
INSM | INSMED INC | $356,000 | +47.1% | 24,536 | 0.0% | 0.17% | -4.4% | |
LJPC | LA JOLLA PHARMACEUTICAL CO | $340,000 | +48.5% | 14,291 | 0.0% | 0.16% | -3.5% | |
ADXS | ADVAXIS INC | $330,000 | +32.0% | 30,885 | 0.0% | 0.16% | -14.0% | |
PRTA | PROTHENA CORP PLC | $330,000 | +71.0% | 5,509 | 0.0% | 0.16% | +11.9% | |
BWP | New | BOARDWALK PIPELINE PARTNERSut ltd partner | $324,000 | – | 18,873 | +100.0% | 0.16% | – |
CEMP | CEMPRA INC | $321,000 | +46.6% | 13,284 | 0.0% | 0.16% | -4.9% | |
ARWR | ARROWHEAD PHARMACEUTICALS IN | $318,000 | +38.3% | 43,272 | 0.0% | 0.15% | -9.9% | |
LXRX | LEXICON PHARMACEUTICALS INC | $319,000 | +26.1% | 17,649 | 0.0% | 0.15% | -18.1% | |
ONCE | SPARK THERAPEUTICS INC | $317,000 | +17.4% | 5,281 | 0.0% | 0.15% | -23.5% | |
SRNE | SORRENTO THERAPEUTICS INC | $313,000 | +38.5% | 40,438 | 0.0% | 0.15% | -10.1% | |
FGEN | FIBROGEN INC | $308,000 | +26.2% | 14,866 | 0.0% | 0.15% | -17.7% | |
FPRX | FIVE PRIME THERAPEUTICS INC | $306,000 | +27.0% | 5,837 | 0.0% | 0.15% | -17.3% | |
FOLD | AMICUS THERAPEUTICS INC | $301,000 | +35.6% | 40,705 | 0.0% | 0.15% | -11.5% | |
KPTI | KARYOPHARM THERAPEUTICS INC | $298,000 | +45.4% | 30,617 | 0.0% | 0.14% | -5.3% | |
NK | NANTKWEST INC | $295,000 | +25.0% | 37,895 | 0.0% | 0.14% | -18.3% | |
AIMT | AIMMUNE THERAPEUTICS INC | $293,000 | +38.9% | 19,501 | 0.0% | 0.14% | -9.6% | |
MGNX | MACROGENICS INC | $292,000 | +11.0% | 9,762 | 0.0% | 0.14% | -27.7% | |
RARE | ULTRAGENYX PHARMACEUTICAL IN | $287,000 | +44.9% | 4,050 | 0.0% | 0.14% | -5.4% | |
ALDR | ALDER BIOPHARMACEUTICALS INC | $281,000 | +31.3% | 8,582 | 0.0% | 0.14% | -14.5% | |
RXDX | IGNYTA INC | $281,000 | +16.1% | 44,599 | 0.0% | 0.14% | -24.4% | |
ALNY | ALNYLAM PHARMACEUTICALS INC | $276,000 | +22.1% | 4,078 | 0.0% | 0.13% | -20.8% | |
TGTX | TG THERAPEUTICS INC | $273,000 | +27.6% | 35,297 | 0.0% | 0.13% | -17.0% | |
KITE | KITE PHARMA INC | $273,000 | +11.9% | 4,889 | 0.0% | 0.13% | -27.1% | |
NBIX | NEUROCRINE BIOSCIENCES INC | $270,000 | +11.6% | 5,324 | 0.0% | 0.13% | -27.2% | |
GBT | GLOBAL BLOOD THERAPEUTICS IN | $270,000 | +39.2% | 11,710 | 0.0% | 0.13% | -9.0% | |
ATRA | ATARA BIOTHERAPEUTICS INC | $271,000 | -4.9% | 12,651 | 0.0% | 0.13% | -38.2% | |
CYTK | CYTOKINETICS INC | $270,000 | -3.2% | 29,379 | 0.0% | 0.13% | -36.7% | |
AGIO | AGIOS PHARMACEUTICALS INC | $268,000 | +26.4% | 5,068 | 0.0% | 0.13% | -17.2% | |
AKBA | AKEBIA THERAPEUTICS INC | $268,000 | +21.3% | 29,590 | 0.0% | 0.13% | -20.7% | |
LOXO | LOXO ONCOLOGY INC | $268,000 | +13.1% | 10,231 | 0.0% | 0.13% | -26.1% | |
LBIO | LION BIOTECHNOLOGIES INC | $269,000 | +1.5% | 32,726 | 0.0% | 0.13% | -34.0% | |
AXGT | AXOVANT SCIENCES LTD | $267,000 | +9.0% | 19,065 | 0.0% | 0.13% | -29.1% | |
IMMU | IMMUNOMEDICS INC | $263,000 | +39.9% | 81,010 | 0.0% | 0.13% | -9.3% | |
ADRO | ADURO BIOTECH INC | $261,000 | +9.7% | 21,010 | 0.0% | 0.13% | -28.8% | |
TRVN | TREVENA INC | $259,000 | +7.0% | 38,367 | 0.0% | 0.12% | -30.6% | |
BGNE | BEIGENE LTDsponsored adr | $257,000 | +3.2% | 8,344 | 0.0% | 0.12% | -33.0% | |
XLRN | ACCELERON PHARMA INC | $250,000 | +6.4% | 6,910 | 0.0% | 0.12% | -30.5% | |
New | SPDR S&P 500 ETF TRcall | $250,000 | – | 200 | +100.0% | 0.12% | – | |
New | TORONTO DOMINION BK ONTnote 3.625% 9/1 | $246,000 | – | 245,000 | +100.0% | 0.12% | – | |
CLDX | CELLDEX THERAPEUTICS INC NEW | $241,000 | -7.7% | 59,537 | 0.0% | 0.12% | -39.7% | |
AVXS | AVEXIS INC | $242,000 | +8.5% | 5,869 | 0.0% | 0.12% | -29.1% | |
OMED | ONCOMED PHARMACEUTICALS INC | $232,000 | -7.2% | 20,269 | 0.0% | 0.11% | -39.8% | |
NS | Buy | NUSTAR ENERGY LP | $228,000 | +50.0% | 4,608 | +50.7% | 0.11% | -2.7% |
ZIOP | ZIOPHARM ONCOLOGY INC | $226,000 | +2.3% | 40,175 | 0.0% | 0.11% | -33.5% | |
INO | INOVIO PHARMACEUTICALS INC | $224,000 | +0.9% | 24,058 | 0.0% | 0.11% | -34.5% | |
PTLA | PORTOLA PHARMACEUTICALS INC | $221,000 | -3.9% | 9,735 | 0.0% | 0.11% | -37.4% | |
ACHN | ACHILLION PHARMACEUTICALS IN | $218,000 | +3.8% | 26,915 | 0.0% | 0.10% | -32.7% | |
OPHT | OPHTHOTECH CORP | $217,000 | -9.6% | 4,702 | 0.0% | 0.10% | -41.0% | |
ESPR | ESPERION THERAPEUTICS INC NE | $215,000 | +39.6% | 15,540 | 0.0% | 0.10% | -8.8% | |
CNCE | CONCERT PHARMACEUTICALS INC | $212,000 | -9.8% | 20,939 | 0.0% | 0.10% | -40.8% | |
EPZM | EPIZYME INC | $214,000 | -4.0% | 21,750 | 0.0% | 0.10% | -37.6% | |
GERN | GERON CORP | $208,000 | -15.4% | 91,851 | 0.0% | 0.10% | -44.8% | |
QURE | UNIQURE NV | $203,000 | +4.1% | 26,511 | 0.0% | 0.10% | -32.4% | |
SGMO | SANGAMO BIOSCIENCES INC | $191,000 | -20.1% | 41,249 | 0.0% | 0.09% | -48.0% | |
ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $190,000 | -13.6% | 26,974 | 0.0% | 0.09% | -43.6% | |
IMGN | IMMUNOGEN INC | $190,000 | -12.8% | 70,796 | 0.0% | 0.09% | -43.2% | |
SEP | Buy | SPECTRA ENERGY PARTNERS LP | $184,000 | +39.4% | 4,205 | +50.8% | 0.09% | -9.2% |
OKE | Buy | ONEOK INC NEW | $185,000 | +63.7% | 3,591 | +51.0% | 0.09% | +6.0% |
JUNO | JUNO THERAPEUTICS INC | $181,000 | -21.6% | 6,017 | 0.0% | 0.09% | -48.5% | |
DVAX | DYNAVAX TECHNOLOGIES CORP | $181,000 | -28.2% | 17,302 | 0.0% | 0.09% | -52.9% | |
IYF | New | ISHARES TRu.s. finls etf | $179,000 | – | 1,986 | +100.0% | 0.09% | – |
AGTC | APPLIED GENETIC TECHNOL CORP | $159,000 | -30.6% | 16,223 | 0.0% | 0.08% | -54.7% | |
IDU | New | ISHARES TRu.s. utilits etf | $154,000 | – | 1,254 | +100.0% | 0.07% | – |
RGLS | REGULUS THERAPEUTICS INC | $153,000 | +14.2% | 46,269 | 0.0% | 0.07% | -25.3% | |
MCRB | SERES THERAPEUTICS INC | $100,000 | -57.4% | 8,098 | 0.0% | 0.05% | -72.4% | |
ITCI | INTRA CELLULAR THERAPIES INC | $98,000 | -60.8% | 6,443 | 0.0% | 0.05% | -74.7% | |
NVAX | NOVAVAX INC | $78,000 | -71.4% | 37,550 | 0.0% | 0.04% | -81.3% | |
New | WILLIAMS COS INC DELcall | $54,000 | – | 350 | +100.0% | 0.03% | – | |
Exit | STATE STR CORP | $0 | – | -300 | -100.0% | -0.00% | – | |
Exit | STATE STR CORP | $0 | – | -150 | -100.0% | -0.01% | – | |
USO | Exit | UNITED STATES OIL FUND LPunits | $0 | – | -1,426 | -100.0% | -0.01% | – |
RLYP | Exit | RELYPSA INC | $0 | – | -28,163 | -100.0% | -0.39% | – |
MDVN | Exit | MEDIVATION INC | $0 | – | -9,058 | -100.0% | -0.40% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VERTEX PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
REGENERON PHARMACEUTICALS | 31 | Q3 2023 | 1.8% |
INCYTE CORP | 31 | Q3 2023 | 2.1% |
ENANTA PHARMACEUTICALS INC | 31 | Q3 2023 | 2.2% |
EXELIXIS INC | 31 | Q3 2023 | 1.8% |
VANDA PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
IRONWOOD PHARMACEUTICALS INC | 31 | Q3 2023 | 2.0% |
LIGAND PHARMACEUTICALS INC | 31 | Q3 2023 | 1.5% |
GILEAD SCIENCES INC | 31 | Q3 2023 | 1.6% |
HALOZYME THERAPEUTICS INC | 31 | Q3 2023 | 1.7% |
View Virtus ETF Advisers LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-15 |
13F-HR | 2023-11-07 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Virtus ETF Advisers LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.